Physician profile
Paul J Marr
NPI 1407854961
$599.66
in general payments reported to CMS, 2019-2025
17 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.47 · 2020: $25.93 · 2021: $28.49 · 2022: $90.54 · 2023: $44.69 · 2024: $79.41 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $379.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $85.67 | 2019-2025 | Orthovisc, Monovisc |
| Stryker Corporation | $69.34 | 2025 | Pangea, Infinity, Flexband |
| Organogenesis INC. | $45.37 | 2022-2025 | Puraply Wound Matrix |
| Ethicon US, LLC | $42.10 | 2024 | Stratafix, Dermabond, Vistaseal |
| Vertex Pharmaceuticals Incorporated | $40.80 | 2025 | |
| Bioventus LLC | $38.19 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Treace Medical Concepts, INC. | $37.82 | 2025 | |
| Paratek Pharmaceuticals, INC. | $37.31 | 2024 | Nuzyra |
| Pacira Pharmaceuticals Incorporated | $35.71 | 2021-2023 | Iovera |
| Zimmer Biomet Holdings, INC. | $26.22 | 2019 | |
| Horizon Therapeutics Plc | $25.89 | 2020-2022 | |
| Curonix LLC | $24.78 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Orthofix Medical, INC. | $23.62 | 2025 | Physio-Stim |
| Ferring Pharmaceuticals INC. | $20.81 | 2019 | |
| Sanofi-Aventis U.S. LLC | $17.27 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $16.19 | 2022 | |
| Zyla Life Sciences, INC. | $12.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Marr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.